Generic Name: Sofosbuvir/ velpatasvir
Brand Name: Epclusa
Manufacturer: Gilead Sciences Canada, Inc.
Therapeutic Area: Hepatitis C, chronic
Indications: Hepatitis C, chronic
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: October 26, 2016
Recommendation Type: Reimburse with clinical criteria and/or conditions